Sabra Health Care REIT (NASDAQ:SBRA) Posts Earnings Results, Hits Expectations

Sabra Health Care REIT (NASDAQ:SBRA) announced its quarterly earnings data on Wednesday. The real estate investment trust reported $0.36 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.36, Zacks reports. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. Sabra Health Care REIT updated its FY 2025 guidance to 1.430-1.460 EPS.

Sabra Health Care REIT Stock Performance

NASDAQ SBRA traded up $0.09 during trading hours on Wednesday, hitting $16.55. 2,383,360 shares of the company’s stock traded hands, compared to its average volume of 2,028,529. Sabra Health Care REIT has a 52 week low of $13.31 and a 52 week high of $20.03. The firm has a market capitalization of $3.92 billion, a P/E ratio of 40.37, a P/E/G ratio of 1.99 and a beta of 1.25. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. The business’s fifty day moving average price is $16.92 and its two-hundred day moving average price is $17.63.

Sabra Health Care REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Friday, February 14th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 7.25%. The ex-dividend date of this dividend is Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 292.69%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on SBRA. Truist Financial cut Sabra Health Care REIT from a “buy” rating to a “hold” rating and decreased their price target for the stock from $18.00 to $17.00 in a research note on Friday, January 17th. JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research report on Tuesday, January 7th. Mizuho reaffirmed a “neutral” rating and set a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Finally, Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. Three research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $18.86.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.